Donzé Jacques D, Beeler Patrick E, Bates David W
Division of General Internal Medicine, Bern University Hospital, Switzerland; Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass; Research Center for Medical Informatics, University Hospital Zurich, Switzerland.
Am J Med. 2016 Aug;129(8):836-42. doi: 10.1016/j.amjmed.2016.02.036. Epub 2016 Mar 24.
The study objective was to compare the 30-day readmission rate and mortality between patients with heart failure who have persistent hyponatremia during hospitalization and patients who have their admission hyponatremia corrected before discharge.
This large retrospective cohort study included all adult patients admitted with a diagnosis of congestive heart failure to a tertiary-care hospital between July 2003 and October 2009. We compared the readmission rate and mortality 30 days after discharge between patients with persistent hyponatremia (ie, low sodium level at both admission and discharge) and patients with hyponatremia correction during hospitalization.
Among the 4295 eligible patients with hyponatremia at admission, 1799 (41.9%) did not have their sodium level corrected at discharge. Overall, 1269 patients (29.5%) had a 30-day unplanned readmission or died. In a multivariable logistic regression analysis, the absence of hyponatremia correction was associated with a 45% increase in the odds of having a 30-day unplanned readmission or death (odds ratio, 1.45; 95% confidence interval, 1.27-1.67). Among patients with persistent hyponatremia, those with more severe hyponatremia at discharge (<130 mm/L) had a higher odds (odds ratio, 1.68; 95% confidence interval, 1.32-2.14) of having a 30-day readmission or death than those with less severe hyponatremia at discharge (130-134 mm/L).
The absence of correction of hyponatremia over the course of hospitalization was frequent and independently associated with an increase of approximately 50% in the odds of having a 30-day unplanned readmission or death. This association appeared to be independent of heart failure severity.
本研究的目的是比较住院期间持续性低钠血症的心力衰竭患者与出院前入院时低钠血症得到纠正的患者之间的30天再入院率和死亡率。
这项大型回顾性队列研究纳入了2003年7月至2009年10月期间在一家三级护理医院因充血性心力衰竭诊断入院的所有成年患者。我们比较了持续性低钠血症患者(即入院和出院时钠水平均低)与住院期间低钠血症得到纠正的患者出院后30天的再入院率和死亡率。
在4295例入院时低钠血症的合格患者中,1799例(41.9%)出院时钠水平未得到纠正。总体而言,1269例患者(29.5%)有30天的非计划再入院或死亡。在多变量逻辑回归分析中,低钠血症未得到纠正与30天非计划再入院或死亡几率增加45%相关(比值比,1.45;95%置信区间,1.27 - 1.67)。在持续性低钠血症患者中,出院时低钠血症更严重(<130 mmol/L)的患者30天再入院或死亡的几率(比值比,1.68;95%置信区间,1.32 - 2.14)高于出院时低钠血症较轻(130 - 134 mmol/L)的患者。
住院期间低钠血症未得到纠正的情况很常见,并且与30天非计划再入院或死亡几率增加约50%独立相关。这种关联似乎独立于心力衰竭的严重程度。